Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
X4 Pharmaceuticals, Inc. (XFOR) had Stock-Based Compensation of $2.03M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.76M |
|
$-29.82M |
|
$0.35M |
|
$1.41M |
|
$29.27M |
|
$-27.51M |
|
$-2.34M |
|
$-29.84M |
|
$-29.84M |
|
$-29.82M |
|
$-29.82M |
|
$-29.82M |
|
$-29.82M |
|
$-27.51M |
|
$-27.29M |
|
43.27M |
|
43.27M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$132.81M |
|
$0.22M |
|
$30.75M |
|
$163.56M |
|
$23.51M |
|
$76.06M |
|
$78.43M |
|
$101.94M |
|
$61.62M |
|
$34.83M |
|
$61.62M |
|
25.15M |
|
| Cash Flow Statement Financials | |
$-70.09M |
|
$-8.70M |
|
$92.54M |
|
$56.48M |
|
$70.44M |
|
$13.96M |
|
|
Stock-Based Compensation |
$2.03M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.65 |
|
-- |
|
-- |
|
0.55 |
|
1.23 |
|
80.11% |
|
-1558.58% |
|
-1558.58% |
|
-- |
|
-1690.93% |
|
-1689.23% |
|
$-70.09M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.09 |
|
1.10 |
|
81.89 |
|
-48.39% |
|
-85.60% |
|
-18.23% |
|
-21.66% |
|
$2.45 |
|
$-1.62 |
|
$-1.62 |
|